William Plovanic
Stock Analyst at Canaccord Genuity
(3.56)
# 869
Out of 4,975 analysts
144
Total ratings
47.29%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by William Plovanic
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HTFL HeartFlow | Initiates: Buy | $35 | $31.07 | +12.65% | 1 | Sep 2, 2025 | |
PODD Insulet | Maintains: Buy | $331 → $353 | $348.43 | +1.31% | 4 | Aug 8, 2025 | |
AORT Artivion | Maintains: Buy | $35 → $41 | $43.49 | -5.73% | 2 | Aug 8, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Buy | $59 → $24 | $12.58 | +90.78% | 5 | Aug 7, 2025 | |
STIM Neuronetics | Maintains: Buy | $8 → $7 | $3.23 | +116.72% | 4 | Aug 6, 2025 | |
IRTC iRhythm Technologies | Maintains: Buy | $139 → $170 | $181.48 | -6.32% | 11 | Aug 1, 2025 | |
DXCM DexCom | Maintains: Buy | $106 | $80.51 | +31.66% | 7 | Aug 1, 2025 | |
EW Edwards Lifesciences | Maintains: Hold | $75 → $81 | $80.94 | +0.07% | 27 | Jul 25, 2025 | |
GMED Globus Medical | Maintains: Buy | $97 → $90 | $60.60 | +48.51% | 4 | Jul 22, 2025 | |
ANGO AngioDynamics | Maintains: Buy | $15 → $17 | $10.73 | +58.43% | 7 | Jul 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $129 → $142 | $104.01 | +36.53% | 6 | Jul 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $105.73 | -4.47% | 3 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $18 | $7.82 | +130.18% | 8 | Apr 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $5.00 | +120.00% | 4 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $52 | $35.38 | +46.98% | 11 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $11.80 | +179.66% | 4 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $117 | $107.22 | +9.12% | 10 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.21 | +108.19% | 4 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $281.46 | +0.90% | 4 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $16.40 | +52.49% | 1 | Jan 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.74 | +589.66% | 5 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $92.96 | -24.70% | 4 | Aug 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $27.94 | +71.80% | 5 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $8.59 | +156.26% | 3 | Jul 25, 2023 |
HeartFlow
Sep 2, 2025
Initiates: Buy
Price Target: $35
Current: $31.07
Upside: +12.65%
Insulet
Aug 8, 2025
Maintains: Buy
Price Target: $331 → $353
Current: $348.43
Upside: +1.31%
Artivion
Aug 8, 2025
Maintains: Buy
Price Target: $35 → $41
Current: $43.49
Upside: -5.73%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Buy
Price Target: $59 → $24
Current: $12.58
Upside: +90.78%
Neuronetics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.23
Upside: +116.72%
iRhythm Technologies
Aug 1, 2025
Maintains: Buy
Price Target: $139 → $170
Current: $181.48
Upside: -6.32%
DexCom
Aug 1, 2025
Maintains: Buy
Price Target: $106
Current: $80.51
Upside: +31.66%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $75 → $81
Current: $80.94
Upside: +0.07%
Globus Medical
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $60.60
Upside: +48.51%
AngioDynamics
Jul 16, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $10.73
Upside: +58.43%
Jul 15, 2025
Maintains: Buy
Price Target: $129 → $142
Current: $104.01
Upside: +36.53%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $105.73
Upside: -4.47%
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $7.82
Upside: +130.18%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.00
Upside: +120.00%
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $35.38
Upside: +46.98%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $11.80
Upside: +179.66%
Feb 6, 2025
Maintains: Buy
Price Target: $101 → $117
Current: $107.22
Upside: +9.12%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.21
Upside: +108.19%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $281.46
Upside: +0.90%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $16.40
Upside: +52.49%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.74
Upside: +589.66%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $92.96
Upside: -24.70%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $27.94
Upside: +71.80%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $8.59
Upside: +156.26%